logo
AAT Bioquest

Screen Quest™ Live Cell Opioid-Like receptor hMOR1 cAMP Assay Service Pack

Product key features

  • Real-time monitoring: Enables precise, live-cell measurement of intracellular cAMP changes in response to hMOR1 activation.
  • Convenient: Provides all necessary components for precise measurement of hMOR1-mediated cAMP changes.
  • High-Throughput: Optimized for use with FLIPR, FDSS, and other fluorescence microplate readers, making it ideal for large-scale screening of hMOR1-targeting compounds.
  • Simple workflow: Utilizes wash-free calcium sensitive dyes reducing assay complexity and time.

Product description

hMOR1, also known as the Human Mu Opioid Receptor (MOR1), is a key member of the G-protein coupled receptor (GPCR) family. hMOR1 is a critical target for opioid-based analgesics and is implicated in various disorders, including chronic pain, opioid addiction, and other neurological conditions. Traditional methods for studying GPCRs may not fully capture the broad spectrum of signaling mechanisms that occur through specific receptors like hMOR1, which couples to both cAMP production and inhibition.

The Screen Quest™ Live Cell Opioid-Like Receptor hMOR1 cAMP Assay Service Pack is designed for real-time, high-throughput monitoring of intracellular cAMP changes associated with hMOR1 activation using transfected cell lines and Calbryte™ 520 wash-free calcium fluorescence detection methods. Unlike conventional assays that require cell lysis, this assay preserves cellular integrity, enabling both temporal and spatial resolution of specific signaling events associated with hMOR1. This assay employs cell lines transfected to express hMOR1 alongside a promiscuous G-protein Gα16. The co-expression of Gα16 enables hMOR1, which normally signals via Gi/o-mediated inhibition of adenylyl cyclase and reduction in intracellular cAMP, to couple to Gq signaling, leading to calcium flux. Activation of hMOR1 by specific ligands such as μ-opioid peptide (endorphins) can be detected using calcium-sensitive dyes such as Calbryte™ 520 AM, Cal-520™ AM, Fluo-8™ AM, Fluo-4™ AM, or other corresponding no-wash calcium kits.

This service pack provides all necessary components for precise measurement of hMOR1-mediated cAMP changes using FLIPR, FDSS, or equivalent fluorescence microplate readers. It enables researchers to explore hMOR1 signaling pathways and evaluate potential therapeutic compounds targeting this receptor, particularly for pain management and addiction-related research.

Example protocol

AT A GLANCE

Protocol summary
  1. Prepare cells for transfection

  2. Prepare Transfectamine™ 5000-DNA mixture

  3. Add Transfectamine™ 5000-DNA mixture to the cell culture, incubate overnight

  4. Transfer the transfected cells to a 96-well plate 24-30 hours after transfection, and incubate the culture overnight

  5. Add Calbryte™ 520 NW dye-loading solution

  6. Incubate at room temperature or 37 °C for 30-60 minutes

  7. Monitor the fluorescence intensity at Ex/Em = 490/525 nm

Important Note

Thaw the kit components at room temperature before starting the experiment.

CELL PREPARATION

  1. Seed the cells such that they will be ~60-70% confluent at the time of transfection.

  2. Replace with fresh growth medium before transfection. For example, replace with 2 mL of medium per well for 6-well plates and 6 mL of medium for 10 cm plates.

PREPARATION OF STOCK SOLUTIONS

Calbryte™ 520NW stock solution
  1. Add 20 µL of DMSO (Component F) into the vial of Calbryte™ 520NW (Component C), and mix them well.

    Note: 20 µL of Calbryte™ 520NW stock solution is enough for one plate. Unused Calbryte™ 520NW stock solution can be aliquoted and stored at < -20 °C for more than one month, provided the tubes are tightly sealed. Protect from light and avoid repeated freeze-thaw cycles.

PREPARATION OF WORKING SOLUTION

1X Assay Buffer
  1. Combine 9 mL of HHBS (Component E) with 1 mL of 10X Pluronic® F127 Plus (Component D), and mix thoroughly.
Calbryte™ 520NW Working Solution
  1. Add 20 µL of Calbryte™ 520 NW stock solution to 10 mL of 1X Assay Buffer, and mix well.

    Note: The working solution is stable for at least 2 hours at room temperature.

Transfectamine™ 5000-DNA Mixture
  1. Add 15 µL of ddH2O to the vial of Ga16 DNA (Component A) and hMOR1 DNA (Component G), to get the final concentration of 1 µg/µL for both DNAs.

  2. Mix 3 µg of DNA [for example, 1.5 µg of Ga16 DNA (Component A) and 1.5 µg of hMOR1 DNA (Component G)] with 200 µL of serum-free medium.

  3. Add 9 µL of Transfectamine™ 5000 (Component B) to the mixture from Step 2.

  4. Mix well and incubate at room temperature for 20 minutes.

    Note: The ratio of Transfectamine™ 5000 and DNA need to be optimized for different  cell lines. In general, the ratio for Transfectamine™ 5000 Transfection Reagent (µL) to DNA (µg) should be 3-5 µL : 1 µg.

Table 1. Sample  protocols for a 6-well plate and a 10 cm plate

Component 6 well plate (per well) 10 cm plate
Fresh culture medium 2 mL 6 mL
Plasmid ~3 µg 10~15 µg
Serum-free medium 200 µL 600 µL
Transfectamine™ 5000 Transfection Reagent ~9 µL ~30-45 µL

SAMPLE EXPERIMENTAL PROTOCOL

Transfection protocol
  1. Add Transfectamine™ 5000 -DNA mixture to the culture plate and incubate overnight.

    Note: The recombinant protein can start to be detected as early as 16 hours after transfection. The maximal expression level may be observed 72~96 hours after transfection.

  2. Transfer the transfected cells to a 96-well plate 24-30 hours post transfection and incubate overnight.

    • For adherent cells: Plate cells overnight in the growth medium at 40,000 to 80,000 cells/well/100 µL for a 96-well plate.
    • For non-adherent cells: Centrifuge the cells from the culture medium and then suspend the cell pellet in cell growth medium or HHBS at 125,000 to 250,000 cells/well/100 µL for a 96-well poly-D lysine plate. Centrifuge the plate at 800 rpm for 2 minutes with brake off prior to the experiments.

    Note: Each cell line should be evaluated on the individual basis to determine the optimal cell density for the intracellular calcium mobilization.

Calcium assay
  1. Add 100 µL/well (96-well plate) of Calbryte™ 520NW working solution into the cell plate.

  2. Incubate the dye-loaded plate in a cell incubator for 30 minutes, and then incubate the plate at room temperature for another 15-30 minutes.

    Note: If the assay requires 37 °C, perform the experiment immediately without further room temperature incubation.

    Note: If the cells can function well at room temperature for longer time, incubate the cell plate at room temperature for 1 hour (It is recommended that the incubation time be no longer than 2 hours.)

  3. Prepare the compound plate with HHBS or your desired buffer.

  4. Run the calcium flux assay by monitoring the fluorescence intensity at Ex/Em = 490/525 nm.

References

View all 50 references: Citation Explorer
Microglial activation and toll-like receptor 4-Dependent regulation of angiotensin II type I receptor-mu-opioid receptor 1 heterodimerization and hypertension in fructose-fed rats.
Authors: Ho, Chiu-Yi and Sun, Gwo-Ching and Lin, Yu-Te and Wong, Tzyy-Yue and Hsiao, Michael and Tseng, Ching-Jiunn and Cheng, Pei-Wen
Journal: European journal of pharmacology (2024): 176171
Functional differences in the mu opioid receptor SNP 118A>G are dependent on receptor splice-variant and agonist-specific recruitment of β-arrestin.
Authors: Patrick, Casey and Ettah, Utibeabasi and Nguyen, Vu and Hart, Caitlin and Atchley, Evan and Mallela, Krishna and Scheinman, Robert I and Monte, Andrew A
Journal: Clinical and translational science (2024): e13888
Relevance of Mu-Opioid Receptor Splice Variants and Plasticity of Their Signaling Sequelae to Opioid Analgesic Tolerance.
Authors: Chakrabarti, Sumita and Liu, Nai-Jiang and Gintzler, Alan R
Journal: Cellular and molecular neurobiology (2021): 855-862
Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1.
Authors: Narayan, Ankita and Hunkele, Amanda and Xu, Jin and Bassoni, Daniel L and Pasternak, Gavril W and Pan, Ying-Xian
Journal: Cellular and molecular neurobiology (2021): 1059-1074
Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
Authors: Liao, Siyan and Tan, Kai and Floyd, Cecilia and Bong, Daegun and Pino, Michael James and Wu, Chun
Journal: Life sciences (2021): 119026
Page updated on January 18, 2025

Ordering information

Price
Unit size
Catalog Number38209
Quantity
Add to cart

Additional ordering information

Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Request quotation

Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22

Platform

Fluorescence microplate reader

Excitation490 nm
Emission525 nm
Cutoff515 nm
Recommended plateBlack wall, Clear bottom
Instrument specification(s)Bottom read mode, Programmable liquid handling

Components